Nanalysis Scientific Corp.
NSCIF
$0.09
$0.00-3.71%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 54.29% | 58.85% | -35.71% | 10.34% | 21.97% |
| Total Depreciation and Amortization | -26.48% | -5.89% | -100.75% | -55.09% | -17.00% |
| Total Amortization of Deferred Charges | -20.38% | -42.91% | 47.53% | 25.88% | 0.37% |
| Total Other Non-Cash Items | -81.92% | -82.41% | 129.98% | 31.57% | 70.78% |
| Change in Net Operating Assets | -45.56% | 175.94% | 1,101.77% | -95.89% | 263.21% |
| Cash from Operations | -85.80% | 1.16% | 598.55% | 222.49% | 173.46% |
| Capital Expenditure | -347.07% | -387.68% | -2.93% | 14.78% | 84.72% |
| Sale of Property, Plant, and Equipment | -32.47% | -37.65% | 205.32% | 500.40% | 18,400.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.28% | 13.29% | 41.03% | 47.52% | 61.80% |
| Cash from Investing | 17.83% | -2.50% | 43.70% | 56.12% | 69.07% |
| Total Debt Issued | -- | -- | -73.09% | -75.47% | -100.00% |
| Total Debt Repaid | -13.20% | 28.63% | 83.24% | 74.10% | 72.79% |
| Issuance of Common Stock | -- | -43.15% | -91.07% | -91.07% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -1,900.00% | -1,900.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.89% | 14.48% | 50.21% | 49.26% | 42.26% |
| Cash from Financing | 120.94% | 121.30% | -101.95% | -187.11% | -132.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.60% | 193.32% | 118.83% | 80.06% | -1,396.05% |